Myotonic dystrophy kinase is a component of neuromuscular junctions.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 8281152)

Published in Hum Mol Genet on November 01, 1993

Authors

P F van der Ven1, G Jansen, T H van Kuppevelt, M B Perryman, M Lupa, P W Dunne, H J ter Laak, P H Jap, J H Veerkamp, H F Epstein

Author Affiliations

1: Department of Cell Biology and Histology, Medical Faculty University Nijmegen, The Netherlands.

Articles by these authors

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (1992) 9.32

An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 8.20

A mutant affecting the heavy chain of myosin in Caenorhabditis elegans. J Mol Biol (1974) 5.33

Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature (1992) 4.45

Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44

Differential localization of two myosins within nematode thick filaments. Cell (1983) 3.84

Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet (1993) 3.10

Segmental flexibility in an antibody molecule. J Mol Biol (1970) 2.92

Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science (1993) 2.75

Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet (1996) 2.47

Identification of genetic elements associated with muscle structure in the nematode Caenorhabditis elegans. Cell Motil (1980) 2.43

Functional analysis of 150 deletion mutants in Saccharomyces cerevisiae by a systematic approach. Mol Gen Genet (1999) 2.26

New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci (2002) 2.18

Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J (1999) 2.07

Paramyosin of Caenorhabditis elegans. J Mol Biol (1974) 2.01

Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem (1998) 1.97

Isolation and sequence analysis of a full-length cDNA for human M creatine kinase. Biochem Biophys Res Commun (1986) 1.96

Immunochemical localization of myosin heavy chain isoforms and paramyosin in developmentally and structurally diverse muscle cell types of the nematode Caenorhabditis elegans. J Cell Biol (1987) 1.92

Complex regional pain syndrome type I (RSD): pathology of skeletal muscle and peripheral nerve. Neurology (1998) 1.86

Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation (1997) 1.81

Temperature-sensitive mutation affecting myofilament assembly in Caenorhabditis elegans. Nature (1974) 1.79

Unc-45 mutations in Caenorhabditis elegans implicate a CRO1/She4p-like domain in myosin assembly. J Cell Biol (1998) 1.78

Myosin and paramyosin are organized about a newly identified core structure. J Cell Biol (1985) 1.76

Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res (1999) 1.72

Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings. Neurology (1992) 1.70

Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int (2007) 1.70

Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia (1994) 1.69

Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation (1990) 1.61

Muscle development in Caenorhabditis elegans: mutants exhibiting retarded sarcomere construction. Cell (1978) 1.61

Paramyosin is necessary for determination of nematode thick filament length in vivo. Cell (1980) 1.60

Myosins exist as homodimers of heavy chains: demonstration with specific antibody purified by nematode mutant myosin affinity chromatography. Cell (1978) 1.60

MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A (1999) 1.59

Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol (1998) 1.57

The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1992) 1.55

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis (2006) 1.54

Ethnic distribution of myotonic dystrophy gene. Lancet (1991) 1.54

Elastin as a biomaterial for tissue engineering. Biomaterials (2007) 1.53

A radiochemical procedure for the assay of fatty acid binding by proteins. Anal Biochem (1983) 1.52

Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation. Mol Cell Biol (1987) 1.52

Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview. Histochem J (1983) 1.50

Three-dimensional structure of recombinant human muscle fatty acid-binding protein. J Biol Chem (1992) 1.49

Human creatine kinase: isolation and sequence analysis of cDNA clones for the B subunit, development of subunit specific probes and determination of gene copy number. Biochem Biophys Res Commun (1987) 1.48

A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr (1986) 1.46

Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology (2008) 1.45

Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum Mol Genet (1993) 1.44

Familial adult-onset muscular dystrophy with leukoencephalopathy. Ann Neurol (1992) 1.40

Monoclonal antibody against human ovarian tumor-associated antigens. J Natl Cancer Inst (1986) 1.40

Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry (2000) 1.39

Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. Clin Cancer Res (1999) 1.38

Immunocytochemical localization of two myosins within the same muslce cells in Caenorhabditis elegans. Cell (1978) 1.37

Intracellular fatty acid-binding proteins. Int J Biochem (1985) 1.36

Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J (1992) 1.35

Fatty acid composition of Bifidobacterium and Lactobacillus strains. J Bacteriol (1971) 1.35

Myosin and paramyosin of Caenorhabditis elegans: biochemical and structural properties of wild-type and mutant proteins. Cell (1977) 1.33

Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet (1992) 1.33

Endocytosis of GPI-linked membrane folate receptor-alpha. J Cell Biol (1996) 1.31

Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. Clin Chim Acta (1986) 1.31

Density-functional theory-symmetry-adapted intermolecular perturbation theory with density fitting: a new efficient method to study intermolecular interaction energies. J Chem Phys (2005) 1.30

An ultrastructural study on the role of Kupffer cells in the process of infection by Plasmodium berghei sporozoites in rats. Parasitology (1983) 1.29

Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids. Structure (1994) 1.29

Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. Leukemia (2011) 1.29

Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet (1993) 1.28

Folding of staphylococcal nuclease: kinetic studies of two processes in acid renaturation. J Mol Biol (1971) 1.28

Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci U S A (1983) 1.28

Transformation of sporozoites of Plasmodium berghei into exoerythrocytic forms in the liver of its mammalian host. Cell Tissue Res (1985) 1.27

Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int (2006) 1.27

Actin and myosin-linked calcium regulation in the nematode Caenorhabditis elegans. Biochemical and structural properties of native filaments and purified proteins. Biochemistry (1977) 1.25

Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials (1999) 1.25

Elimination of autofluorescence in immunofluorescence microscopy with digital image processing. J Histochem Cytochem (1995) 1.25

Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res (2002) 1.23

Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril (1991) 1.23

Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging (1990) 1.22

14CO2 production is no adequate measure of [14C]fatty acid oxidation. Biochem Med Metab Biol (1986) 1.22

Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials (2001) 1.22

Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry (2004) 1.21

Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cancer (2005) 1.21

Two homogeneous myosins in body-wall muscle of Caenorhabditis elegans. Cell (1977) 1.21

Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J (1991) 1.20

Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. Blood (1999) 1.20

Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta (1988) 1.20

The alteration of myosin isoform compartmentation in specific mutants of Caenorhabditis elegans. J Cell Biol (1986) 1.20

Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20

Anticipation in myotonic dystrophy. II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology (1992) 1.20

A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19

Brief report: reverse mutation in myotonic dystrophy. N Engl J Med (1993) 1.19

Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials (2000) 1.18

Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics (1977) 1.18

A hemodynamic load in vivo induces cardiac expression of the cellular oncogene, c-myc. Biochem Biophys Res Commun (1987) 1.18